Justin Mason-Home is a Fellow of the Royal Society of Chemistry, with over 20 years’ experience in supporting pharma companies manage potent drug safety. He is a pharma insider, is published and a frequent chair/presenter at international HPAPI conferences. Justin formed HPSL in 2017, offering a high-level, practically focused and pragmatic resource, to support (bio)pharma companies design, develop and deliver potent and HPAPI projects; from R&D, scale-up and formulation development, right through to full scale manufacturing. Mr Mason-Home has been involved in and worked on potent and highly potent API projects over more than 22 years and specialises in technical complex and strategic projects, including unique experience in managing sensitive highly potent and toxic biopharmaceutical compound matters.
Share This Speaker